Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 2/20 | 0.53 |
| ▸ | NCF1 | P14598 | 4/20 | 0.51 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.39 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6377939 | 0.83 | NCF1 (0.48) | CHRM4NCF1KMT2APDE10A | |
| SCHEMBL5037477 | 0.83 | MAOA (0.48) | CHRM4NCF1MAOAMAOBKMT2A | |
| Hydrochloric Acid SCHEMBL5040546 | 0.82 | MAOA (0.50) | CHRM4NCF1MAOAMAOBKMT2A | |
| SCHEMBL5036263 | 0.80 | NCF1 (0.61) | NCF1KMT2AADRB2ADRB1MEN1 | |
| Hydrochloric Acid SCHEMBL6377887 | 0.79 | NCF1 (0.59) | NCF1KMT2AADRB2ADRB1MEN1 | |
| SCHEMBL5873086 | 0.79 | NCF1 (0.63) | NCF1KMT2AADRB2ADRB1MEN1 | |
| SCHEMBL5035794 | 0.78 | NCF1 (0.52) | CHRM4NCF1MAOAMAOBKMT2A | |
| Hydrochloric Acid SCHEMBL5033349 | 0.77 | NCF1 (0.51) | CHRM4NCF1MAOAMAOBKMT2A | |
| SCHEMBL5033185 | 0.77 | NCF1 (0.57) | CHRM4NCF1KMT2AADRB2ADRB1 | |
| SCHEMBL5040479 | 0.77 | NCF1 (0.57) | NCF1KMT2AADRB2ADRB1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050049413-A1 | Quinoline derivatives | MUELLER WERNER (CH) | 2005-03-03 | — | — | US | disclosed |
| US-6818767-B2 | NEUROPEPTIDE Y (NPY) ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF ARTHRITIS, CARDIOVASCULAR DISEASES, DIABETES, RENAL FAILURE, EATING DISORDERS, OR OBESITY | HOFFMANN-LA ROCHE INC. | 2004-11-16 | — | — | US | disclosed |
| US-20020198194-A1 | Quinoline derivatives | HOFFMANN-LA ROCHE INC. | 2002-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020198194-A1 | Quinoline derivatives | NPY2R, NPY1R, NPY4R | CHRM4 2051/4885NCF1 1052/4885MAOA 1633/4885 |
| US-20050049413-A1 | Quinoline derivatives | NPY2R, NPY1R, NPY4R | CHRM4 2051/4885NCF1 1052/4885MAOA 1633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.